PMID,Title,Journal,Year
38058171,An update on combination therapies for multiple sclerosis: where are we now?,Expert review of neurotherapeutics,2023
33296982,Does oral salbutamol improve fatigue in multiple sclerosis? A pilot placebo-controlled study.,Multiple sclerosis and related disorders,2020
31128979,Association Between Exposure of Ipratropium and Salmeterol and Diagnosis of Multiple Sclerosis: A Matched Case-control Study.,Clinical therapeutics,2019
28860381,beta2-Adrenoreceptor is a regulator of the alpha-synuclein gene driving risk of Parkinson's disease.,"Science (New York, N.Y.)",2017
24732071,Beta2-adrenergic agonist use and the risk of multiple sclerosis: a total population-based case-control study.,"Multiple sclerosis (Houndmills, Basingstoke, England)",2014
20837847,A randomized controlled double-masked trial of albuterol add-on therapy in patients with multiple sclerosis.,Archives of neurology,2010
17225731,Beta2-agonists and paresthesias in multiple sclerosis.,"Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology",2007
11772115,Potential of beta2-adrenoceptor agonists as add-on therapy for multiple sclerosis: focus on salbutamol (albuterol).,CNS drugs,2002
11431016,Oral salbutamol decreases IL-12 in patients with secondary progressive multiple sclerosis.,Journal of neuroimmunology,2001
